Industri

Neurovascular Medical Device Companies: Driving A New P...

Neurovascular disorders are recognized among the top five life-threatening condi...

Building Tomorrow’s Therapies Today: The Evolution of C...

The American Society of Gene and Cell Therapy (ASGCT) defines cell therapy as a ...

Emerging Trends in Protein Expression Systems: Growth O...

Protein therapeutics have completely revolutionized the healthcare segment, grea...

Key Trends in the Microbial CMO Market

Benefits offered by microbial manufacturing, such as low production costs and fa...

Reflecting on BioTechX 2025 — Where Data, AI, and Innov...

We’ve just had an incredible three days at BioTechX in Basel, a truly inspiring ...

​Are Rare Earth Elements Rare? NO, but some are rarer t...

​Our most famous metal, gold, is far rarer than any rare earth! When gold is fou...

From Fossil Fuels to Data: The Evolving Identity of Oil...

​Oil and gas companies are usually defined by the fossil fuels they explore, pro...

Subcutaneous Biologics Market Analysis: Current Trends ...

Over the years, the incidence and prevalence of chronic diseases, such as diabet...

Radiopharmaceutical Manufacturing: A Multi-Disciplinary...

Nuclear medicine is a medical specialty that involves the use of radionuclides o...

The Future of Autonomous Deliveries: Integrating Drones...

As technology is rapidly evolving, so is each sector related to it. The delivery...

Sentynl Therapeutics appoints myTomorrows as global pro...

Partnership aims to expand access to treatment options for Hutchinson-Gilford P...

Glenmark to launch Leucovorin Calcium 350 mg/vial in De...

The single-dose vial is bioequivalent to Hospira’s reference product and will ...

Cipla launches Yurpeak (tirzepatide) for obesity and ty...

Company to distribute and promote the once-weekly injectable therapy following ...

Formycon and Zydus sign exclusive agreement for FYB206 ...

Formycon will complete the development of FYB206, prepare and file the regulator...

Health Canada approves Biogen’s Zurzuvae for PPD treatment

The once-daily oral therapy is administered as a 14-day course. Clinical trials ...

Servier India secures CDSCO approval for Vorasidenib fo...

Approval enables access to targeted therapy for adults and adolescents aged 12 ...